Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Leszath Pharma was a pharmaceutical company based in Singapore and the United States, with some early-stage activity and a pre-seed funding round of $210,000 announced in January 2020. There is no public record of clinical results or advanced pipeline progress. The company appears to have become inactive and was later acquired/renamed as Amyriad Pharma, Inc.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Leszath Pharma.